AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
16min chapter
Donanemab: A New Ray of Hope in the Fight Against Alzheimer's
The Brain Health Revolution Podcast
Eli Lilly's Donanemab: A New Alzheimer's Drug
This chapter discusses Eli Lilly's new Alzheimer's drug called Donanemab, a monoclonal antibody that targets the toxic amyloid beta protein in the brain. It explores the controversy surrounding the role of amyloid in Alzheimer's disease and introduces a study on the effects of Donanemab in individuals with early Alzheimer's. The chapter also highlights the importance of properly communicating the results and addressing potential side effects.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode